NCT03804606View on ClinicalTrials.gov

Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure

NATerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Heart Failure
Interventions
OTHER

Referral to MTM Pharmacist

Patients will be referred for an encounter with a medication therapy management pharmacist.

Trial Locations (1)

17822

Geisinger Health System, Danville

Sponsors

Lead Sponsor

Geisinger Clinic
All Listed Sponsors
lead

Geisinger Clinic

OTHER

NCT03804606 - Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure | Biotech Hunter | Biotech Hunter